This federal contract award, with an ID of SPE2DB20D2002|SPE2DB25FL06B, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Jardiance 10 mg tablets, a pharmaceutical product used for the treatment of diabetes. The contract has a firm fixed price of $5,293.62 and an ultimate completion date of December 4, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, and this contract is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award was not designated as a set-aside.
Generated 3/4/25, 11:40 AM